StockTipsArenaBeta

BUY Sun Pharmaceutical Industries Ltd. — Sumeet Bagadia, Choice Broking

BUYSun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries share price target & all analyst calls

bySumeet Bagadia, Choice BrokingHorizon: NA (inferred Intraday)29 Sept 2026, 10:58 am ISTvia Zee Business (Live)

Entry₹1,846.9Inferred
Target₹1,875
Total upside +1.52% (call closed)
Stop loss₹1,825-1.19% risk
At expiry₹1,850.129 Sept 2026, 3:05 pm
Expired+0.17%
Follow Sumeet Bagadia for new calls(15% target hit, 84 closed calls)Get alertsWatch SUNPHARMA for new buy/sell callsGet alerts

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 29 Sept 2026
2 supporting0 opposing
Supports the BUY call (2)

Sun Pharmaceutical has entered into a licensing agreement for lerodalcibep, a novel drug candidate, expanding its specialty portfolio.

BSE · Company Update·28 Sept · yesterday

(opens in new tab)

2 advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · adjacent horizon·21 Sept · 1w ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Sun Pharmaceutical Industries

All analyst calls on Sun Pharmaceutical Industries

More from Sumeet Bagadia, Choice Broking

Every call and its outcome